Archive
Proactive news snapshot: Nektan, 88 Energy, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:HEMO
Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
128 stories · page 4 of 7
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Hemogenyx is already working with the unnamed company to further develop its CDX antibodies and it hopes to open talks over a possible licensing deal in the coming weeks
Investments and investor services
The FTSE 250 on the other hand, a better gauge of UK companies, added over 180 points at 17,976
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's maor movers, including Carnival, EKF, Chamberlin, Panthera, NetScientific and Yu Group
"Investors aren’t willing to forgive Fed Chair Jeremy Powell yet; a soft open on Wall Street threatens to drag the FTSE lower into the close," said Fiona Cincotta at City Index
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's shakers and quakers, including Hiscox, Serica Energy, SIMEC Atlantis, Symphony Environmental, Kore Potash, Angus Energy and TomCo Energy
FTSE 100 closed marginally higher but mid-cap cousin FTSE 250 plunged nearly ten points.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Monday …
This time around, the investment is centred on Hemogenyx’s Hu-PHEC technology - a cell replacement product candidate that is being developed to generate cancer-free, patient-matched blood stem cells after transplantation into the patient
The UK's premier index of leading shares closed down seven points, or 0.10% at 7,042
A look at some winners and losers in UK equity trading during Friday's session
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
The biopharmas will work together to develop Hemogenyx’s AHC technology, while Orgenesis will invest at least US$1mln in Hemogenyx through a convertible loan
The UK blue-chip index closed up almost 23 points at 7,049 - up around 0.77% on the week as a whole
Archive
A glance at some of the day's highlights from the Proactive Investors newswire